Popular on eTradeWire
- Snell & Wilmer's Heidi McNeil Staudenmaier Among Attorney Intel's Top 25 Arizona Attorneys
- iLogistics Tecnologia Nombrado Uno de los Mejores Lugares Para Trabajar en Santiago
- The Market at 3 West Ridge Benefiting HUGS & P.A.C.K. to Be Held Feb. 7-9
- KingdomAdvertising.net Advertising Kiosks are now available at Car Washes and Gas Stations
- The Schmidt Boca Raton History Museum Announces Several Special Events in January & February
- Snell & Wilmer Announces New Partners and Counsel
- Knobull Provides Job-Winning Resumes Custom-Tailored To You!
- Zekri Reelected to the Association of Family Law Professionals Board
- DFCR Gathers Support for New York State to Adopt Universal Cannabis Product Symbol
- W.D.O.P.E. Dopetrackz Radio - Rap Music Station THE INTERNET'S #1 Station for Underground Rap
Similar on eTradeWire
- IISE announces leadership election results
- Calvetta Phair, CEO of America's Workforce Solution, LLC, Charitable Partner - 'The On It Foundation' Qualify to Distribute Google Career Certificates
- Poshpad LA Medspa in Culver City Los Angeles offers the best treatments such as Botox, Microneedling, PRP injections, Chemical Peels and much more
- Meditation Doesn't Help Just the Mind, But the Body Too
- New Book Launches to Bestseller Status--Answers the Question "Why Is It So Hard to Find Quality Workers?"
- The Anderson Periodontal Wellness Office Now Uses Zirconia Dental Implants to Restore Smiles!
- Health systems leaders gather in Louisville to discuss innovative solutions
- Practolytics opens its second office in Atlanta, GA to provide end-to-end RCM solutions
- MAGNETIC Drive Gear Pumps Micro Sized
- Can Massage Therapy Be an Effective Treatment for Long Haul COVID?
FDA Clears New Laboratory Blood Glucose Reference Analyzer from Nova Biomedical
eTradeWire News/10706108
WALTHAM, Mass. - eTradeWire -- The U.S. Food and Drug Administration (FDA) has cleared Nova Primary as a blood glucose reference analyzer. Nova Primary fills the need for a new glucose reference analyzer to replace the discontinued YSI STAT PLUS 2300 Glucose and L-Lactate analyzer (YSI, Inc., Yellow Springs, OH).
Manufacturers of blood glucose measuring devices and clinical diabetes researchers have relied on the YSI 2300 as a reference and correlation analyzer. However, YSI, Inc. no longer supports the analyzer, and its discontinuation has left a critical industry void. The Nova Primary analyzer fills that need. With today's FDA clearance, Nova Primary is now available in the U.S. and worldwide. According to Matthew McRae, Nova Sales Product Line Manager, "We at Nova Biomedical are pleased to offer the Nova Primary, an accurate, easy-to-use and modernized blood glucose reference analyzer for glucose device manufacturers and clinical diabetes researchers to replace the discontinued YSI Stat Plus glucose analyzer."
More on eTradeWire News
Like the YSI 2300, Nova Primary uses a single, reusable glucose electrochemical sensor based on glucose oxidase and has a measurement range of 20-900 mg/dL. It uses a small, 25 microliter venous whole blood or plasma sample which is internally diluted as in the YSI. Results are available in approximately 2 minutes. Nova Primary's large color touchscreen display and intuitive, icon-based graphical user interface make it very straightforward to use. A single calibrator pack uses RFID data management to monitor the pack expiration date and number of samples remaining, eliminating the need for separate reagent bottles and daily monitoring of their levels. In clinical laboratory studies using venous whole blood and plasma, the Nova Primary demonstrated excellent correlation to the YSI 2300 and is traceable to NIST glucose standards. The Nova Primary uses a comma delimited (.csv) format data output that can be downloaded via the integral USB data port. The analyzer measures 17 in x 11 in x 18 in (44 cm x 28 cm x 46 cm).
More on eTradeWire News
About Nova Biomedical
Incorporated in 1976 and based in Waltham, MA, Nova Biomedical is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers, as well as instruments for cell culture monitoring in the biotechnology market. Nova uses biosensor technology in products ranging from handheld meters for glucose self- and point-of-care testing to critical care whole blood analyzers designed for stat measurement of over 22 analytes. Nova employs over 1,400 people worldwide and has wholly owned subsidiaries located in Benelux, Brazil, Canada, France, Germany, Great Britain, Italy, Japan, Spain, and Switzerland.
Manufacturers of blood glucose measuring devices and clinical diabetes researchers have relied on the YSI 2300 as a reference and correlation analyzer. However, YSI, Inc. no longer supports the analyzer, and its discontinuation has left a critical industry void. The Nova Primary analyzer fills that need. With today's FDA clearance, Nova Primary is now available in the U.S. and worldwide. According to Matthew McRae, Nova Sales Product Line Manager, "We at Nova Biomedical are pleased to offer the Nova Primary, an accurate, easy-to-use and modernized blood glucose reference analyzer for glucose device manufacturers and clinical diabetes researchers to replace the discontinued YSI Stat Plus glucose analyzer."
More on eTradeWire News
- The Swig Company Announces Long-Term Lease with Silicon Valley Community Foundation in Mountain View
- BayView Entertainment and Paris Films Enter First Look Agreement
- Tarps Now® Releases Guide to Best Tarps to Buy
- IISE announces leadership election results
- JD Merit & Co. Advises Amtech Systems, Inc. in its Acquisition of Entrepix, Inc
Like the YSI 2300, Nova Primary uses a single, reusable glucose electrochemical sensor based on glucose oxidase and has a measurement range of 20-900 mg/dL. It uses a small, 25 microliter venous whole blood or plasma sample which is internally diluted as in the YSI. Results are available in approximately 2 minutes. Nova Primary's large color touchscreen display and intuitive, icon-based graphical user interface make it very straightforward to use. A single calibrator pack uses RFID data management to monitor the pack expiration date and number of samples remaining, eliminating the need for separate reagent bottles and daily monitoring of their levels. In clinical laboratory studies using venous whole blood and plasma, the Nova Primary demonstrated excellent correlation to the YSI 2300 and is traceable to NIST glucose standards. The Nova Primary uses a comma delimited (.csv) format data output that can be downloaded via the integral USB data port. The analyzer measures 17 in x 11 in x 18 in (44 cm x 28 cm x 46 cm).
More on eTradeWire News
- 2023 Book Award Winners Announced
- Brian Lottermann Promoted to Agent at Universal Attractions Agency
- Custom Engraved Firefighter Coins Make A Great Retirement Gift
- Tyler Clark Joins Global Learning Charter Public School as a Grade 5 ELA Teacher
- KITROBOT Intelligent System Corp. Introduces an AI-Powered Disinfecting Robot For Automated Cleaning
About Nova Biomedical
Incorporated in 1976 and based in Waltham, MA, Nova Biomedical is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers, as well as instruments for cell culture monitoring in the biotechnology market. Nova uses biosensor technology in products ranging from handheld meters for glucose self- and point-of-care testing to critical care whole blood analyzers designed for stat measurement of over 22 analytes. Nova employs over 1,400 people worldwide and has wholly owned subsidiaries located in Benelux, Brazil, Canada, France, Germany, Great Britain, Italy, Japan, Spain, and Switzerland.
Source: Nova Biomedical
0 Comments
Latest on eTradeWire News
- Daugherty Business Solutions Named a Top Workplace by Energage
- New publication helps lawyers develop the skills needed for business development
- Cohen Woodworking Names Alan Turner Plant Manager
- Leeds College of Building Showcases Higher-Level Training for National Apprenticeship Week 2023
- Plymouth Terrace Senior Living Provides Memory Care Activities to Keep Seniors Active & Engaged
- How to Make Choosing an Assisted Living Facility for Your Male Loved One Easier
- Stay Hydrated at Work with the Drinkmate OmniFizz Carbonation Machine
- Colorado Workers' Compensation Attorneys Defend Clients in Ski Resort Workplace Accidents
- Climate Institute Signs Agreement with Swiss-Based 2000-Watt Smart Cities Association to Promote New Climate Change Programs in the United States
- Superryor Launches Mission to Ignite Transformative Journey of Healing through Non-Fiction Books
- Author Terence Ang Announces A Gift From The Heart
- Wildflower Bee Farm publishes new book "What Grandpa Learned from His Honeybees"
- Rosann Santos Discusses The Need For More Bias And Sensitivity Training in The NBA
- Bradford College Celebrates National Apprenticeship Week 2023
- North Carolina Kikos Awarded WNC AgOptions Technology Grant
- Proactive Lending Group Reveals Why Dallas Is The Safest Place To Invest in Real Estate
- Calvetta Phair, CEO of America's Workforce Solution, LLC, Charitable Partner - 'The On It Foundation' Qualify to Distribute Google Career Certificates
- Health 2.0 Conference Is Back With Its Latest Edition To Review The Healthcare Disruptions
- Leading Cybersecurity Experts To Unite To Address Growing Problem of Online Fraud at Internet 2.0 Conference
- Fashion Umbrella Foundation Membership Returns